Announce Date | 09/18/2025 |
EPS Normalized Actual | $1.97 (Miss by $-0.03) |
EPS GAAP Actual | $1.97 (Miss by $-0.03) |
Revenue Actual | $3.0447B |
Revenue Surprise | Beat by $3044.7M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
May 2030 | 14.83 | 12.48 | 14.47669 | 15.02868 | 2 |
May 2030 | 14.47 | 12.79 | 14.11966 | 14.80329 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.21 | 2.21 | 3.0447B | 9.45% | 3044.7M |
FQ2 2025 (May 2025) | 2.59 | 2.59 | 3.2717B | 9.61% | 3271.7M |
FQ1 2025 (Feb 2025) | 2.76 | 2.76 | 3.158B | 5.8% | 3158M |
FQ4 2024 (Nov 2024) | 1.83 | 1.83 | 2.89B | 5.63% | 2890M |
FQ3 2024 (Aug 2024) | 1.75 | 1.75 | 2.757B | 0.96% | 2757M |
FQ2 2024 (May 2024) | 2.58 | 2.58 | 2.9573B | 6.37% | 2957.3M |
FQ1 2024 (Feb 2024) | 2.62 | 2.62 | 2.9748B | 6.34% | 2974.8M |
FQ4 2023 (Nov 2023) | 1.77 | 1.77 | 2.7273B | 8.83% | 2727.3M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 3.82806 | -- | 3.7088 | 3.89739 | 10 |
FQ1 2028 (Feb 2028) | 3.58342 | -- | 3.47179 | 3.64832 | 10 |
FQ4 2027 (Nov 2027) | 2.64414 | -- | 2.56177 | 2.69203 | 9 |
FQ3 2027 (Aug 2027) | 2.37465 | -- | 2.30067 | 2.41766 | 9 |
FQ2 2027 (May 2027) | 3.49198 | -- | 3.39945 | 3.56099 | 11 |
FQ1 2027 (Feb 2027) | 3.36421 | -- | 3.30405 | 3.47492 | 12 |
FQ4 2026 (Dec 2026) | 2.38533 | -- | 2.32655 | 2.42751 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2028 (May 2028) | 3.78B | -- | 3.69B | 3.83B | 7 |
FQ1 2028 (Feb 2028) | 3.66B | -- | 3.57B | 3.71B | 7 |
FQ4 2027 (Nov 2027) | 3.41B | -- | 3.33B | 3.46B | 8 |
FQ3 2027 (Aug 2027) | 3.38B | -- | 3.3B | 3.43B | 8 |
FQ2 2027 (May 2027) | 3.52B | -- | 3.45B | 3.58B | 11 |
FQ1 2027 (Feb 2027) | 3.54B | -- | 3.49B | 3.63B | 15 |
FQ4 2026 (Dec 2026) | 3.12B | -- | 3.06B | 3.17B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.21 | 2.21 | 100% | |
FQ2 2025 (May 2025) | 2.59 | 2.59 | 100% | |
FQ1 2025 (Feb 2025) | 2.76 | 2.76 | 100% | |
FQ4 2024 (Nov 2024) | 1.83 | 1.83 | 100% | |
FQ3 2024 (Aug 2024) | 1.75 | 1.75 | 100% | |
FQ2 2024 (May 2024) | 2.58 | 2.58 | 100% | |
FQ1 2024 (Feb 2024) | 2.62 | 2.62 | 100% | |
FQ4 2023 (Nov 2023) | 1.77 | 1.77 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | $0B | $3.04B | $3044.7M | 100% |
FQ2 2025 (May 2025) | $0B | $3.27B | $3271.7M | 100% |
FQ1 2025 (Feb 2025) | $0B | $3.16B | $3158M | 100% |
FQ4 2024 (Nov 2024) | $0B | $2.89B | $2890M | 100% |
FQ3 2024 (Aug 2024) | $0B | $2.76B | $2757M | 100% |
FQ2 2024 (May 2024) | $0B | $2.96B | $2957.3M | 100% |
FQ1 2024 (Feb 2024) | $0B | $2.97B | $2974.8M | 100% |
FQ4 2023 (Nov 2023) | $0B | $2.73B | $2727.3M | 100% |